These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36896302)

  • 1. Network meta-analysis of the prognosis of curative treatment strategies for recurrent hepatocellular carcinoma after hepatectomy.
    Chen JL; Chen YS; Ker CG
    World J Gastrointest Surg; 2023 Feb; 15(2):258-272. PubMed ID: 36896302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal treatment strategy for recurrent hepatocellular carcinoma based on recurrence time and tumor size: A propensity score matching study.
    Wan W; Zhang H; Ji T; Zhang L; Luo K; Xiong D
    Clin Res Hepatol Gastroenterol; 2023 Aug; 47(7):102157. PubMed ID: 37321321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
    Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
    Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
    Yeow M; Zhao JJ; Fong KY; Wong J; Tan AYH; Kam JH; Nikfarjam M; Goh BKP; Kabir T
    World J Surg; 2022 Nov; 46(11):2778-2787. PubMed ID: 35989371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency ablation versus hepatic resection for recurrent hepatocellular carcinoma: an updated meta-analysis.
    Yang D; Zhuang B; Wang Y; Xie X; Xie X
    BMC Gastroenterol; 2020 Nov; 20(1):402. PubMed ID: 33246417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of microvascular invasion guides treatment strategy in recurrent HBV-related HCC.
    Chen SL; Xiao H; Xie ZL; Shen JX; Chen ZB; Wang YQ; Li B; Peng ZW; Kuang M; Lai JM; Peng S
    Eur Radiol; 2020 Jun; 30(6):3473-3485. PubMed ID: 32048035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trans-arterial chemoembolization + radiofrequency ablation versus surgical resection in hepatocellular carcinoma - A meta-analysis.
    Gui CH; Baey S; D'cruz RT; Shelat VG
    Eur J Surg Oncol; 2020 May; 46(5):763-771. PubMed ID: 31937433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison on the efficacy and prognosis of different strategies for intrahepatic recurrent hepatocellular carcinoma: A systematic review and Bayesian network meta-analysis.
    Zheng J; Cai J; Tao L; Kirih MA; Shen Z; Xu J; Liang X
    Int J Surg; 2020 Nov; 83():196-204. PubMed ID: 32980518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment selection of recurrent hepatocellular carcinoma with microvascular invasion at the initial hepatectomy.
    Xiao H; Chen ZB; Jin HL; Li B; Xu LX; Guo Y; Chen SL; Li HP; Peng ZW; Shen JX
    Am J Transl Res; 2019; 11(3):1864-1875. PubMed ID: 30972210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic resection alone versus in combination with pre- and post-operative transarterial chemoembolization for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.
    Qi X; Liu L; Wang D; Li H; Su C; Guo X
    Oncotarget; 2015 Nov; 6(34):36838-59. PubMed ID: 26451613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency ablation versus reresection in treating recurrent hepatocellular carcinoma: a meta-analysis.
    Cai H; Kong W; Zhou T; Qiu Y
    Medicine (Baltimore); 2014 Nov; 93(22):e122. PubMed ID: 25396332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial Chemoembolization Combined With Radiofrequency Ablation
    Zheng X; Ren Y; Hu H; Qian K
    Front Oncol; 2021; 11():713432. PubMed ID: 34568043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of surgical resection for multiple hepatocellular carcinomas.
    Choi SH; Choi GH; Kim SU; Park JY; Joo DJ; Ju MK; Kim MS; Choi JS; Han KH; Kim SI
    World J Gastroenterol; 2013 Jan; 19(3):366-74. PubMed ID: 23372359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
    Kuo MJ; Mo LR; Chen CL
    BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeat hepatectomy versus percutaneous ablation for recurrent hepatocellular carcinoma: emphasis on the impact of early or late recurrence.
    Wang C; Li K; Huang Z; Yuan Y; He W; Zheng Y; Zou R; Li B; Yuan Y; Qiu J
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):15113-15125. PubMed ID: 37632543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
    Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
    BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy and safety of repeated hepatectomy and radiofrequency ablation in the treatment of primary recurrent liver cancer: a meta-analysis.
    Chen Z; Wang J; Lin Y
    World J Surg Oncol; 2022 Jun; 20(1):182. PubMed ID: 35668464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma.
    Matsumoto M; Yanaga K; Shiba H; Wakiyama S; Sakamoto T; Futagawa Y; Gocho T; Ishida Y; Ikegami T
    Ann Gastroenterol Surg; 2021 Jul; 5(4):538-552. PubMed ID: 34337303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of radiofrequency ablation following transarterial chemoembolisation combined with sorafenib for intermediate stage recurrent hepatocellular carcinoma: a retrospective, multicentre, cohort study.
    Wang XH; Duan WB; Liang W; Li H; Xie XY; Li SQ; Chen MS; Liang P; Mao XH; Zhou QF
    EClinicalMedicine; 2023 Feb; 56():101816. PubMed ID: 36703645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transarterial Chemoembolization Combined With Radiofrequency Ablation Versus Hepatectomy for Hepatocellular Carcinoma: A Meta-Analysis.
    Dan Y; Meng W; Li W; Chen Z; Lyu Y; Yu T
    Front Surg; 2022; 9():948355. PubMed ID: 35898584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.